White adipose tissue now emerges as a pivotal organ controlling lifespan. Calorie restriction, which so far extends lifespan in all organisms, primarily affects energy stores in adipose tissue. Genetic manipulations aiming at modifying fat mass also impact on the duration of life in several model organisms. We recently proposed that silent information regulator 2 (SIR2) ortholog, sirtuin 1 (SIRT1), the mammalian ortholog of the life-extending yeast gene SIR2, is involved in the molecular mechanisms linking lifespan to adipose tissue. SIRT1 represses peroxisome proliferator-activated receptors gamma transactivation and inhibits lipid accumulation in adipocytes. The effect of adipose tissue reduction on lifespan could be due to the production of adipokines acting on target tissues such as the brain, or due to the indirect prevention of age-related metabolic disorders like type 2 diabetes or atherosclerosis.
Introduction
Human lifespan has increased enormously in the last century. Reduced mortality rates are observed worldwide, including Canada, where it is estimated that lifespan will reach 85 y in 2050. 1 By that time, it is expected that 5% of the population will be 85 y old and older, compared to 1% in 1994, which corresponds to a 275% increase from 1960 statistics. As aging increases vulnerability to pathologies, the rate of age-related health complications has also increased during this period, along with the exponentially growing economic costs that the treatment of these diseases has generated. Aging is defined as a decline in survival and fecundity with advancing age, which is caused by damage to macromolecules and tissues. Rapid progress in aging research has been made by using classic genetic approaches, and several mutations that increase longevity in the yeast Saccharomyces cerevisiae, the nematode Caenorhabditis elegans, and the fruit fly Drosophila melanogaster have been identified. As a single mutation can affect lifespan, aging can be seen as genetically determined, a concept supported by the large differences between species. It appears that multiple processes, such as neuroendocrine signaling, mitochondrial functions, and nutritional sensing, can all contribute to lifespan determination. [2] [3] [4] Metabolic pathways involved in nutritional sensing are especially important and relevant to this present review, because they converge with mechanisms involving crucial regulators of energy homeostasis. In worms, the insulin-like growth factor one (IGF-1)/insulin signaling pathway is a central integrator of longevity. Mutations affecting the insulin receptor or its downstream signaling targets all impact on lifespan to some degree. 4 These mutations influence the entry of worms into a dauer stage, in which the animal stops reproductive functions and accumulates fat, which highlights the relationship between aging and energy metabolism. In mammals, this association is best illustrated by the life-extending effect of calorie restriction (CR). In all mammalian species studied so far, the CR regimen (ie, a reduction in the amount of energy ingested associated with constant amount of micronutrients such as vitamins and minerals) extends the lifespan, but the precise mechanisms responsible for this effect are not fully determined. 5, 6 Studies in yeast argue that CR is a highly regulated response to food deprivation, which requires a sensing step followed by the execution of a genetic program to extend the lifespan 7, 8 One possible regulatory gene mediating this program is silent information regulator 2 (SIR2), which stimulates survival in yeast, 9 C. elegans, 10 and, perhaps, higher eukaryotes in response to food scarcity. The SIR2 gene is well suited for this function because it encodes a nuclear NAD-dependent protein deacetylase, [11] [12] [13] enabling it to monitor cellular metabolism and exert corresponding effects on gene expression. CR also induces resistance to oxidative and heat stress. These changes may be mediated by the mammalian SIR2 ortholog, sirtuin 1 (SIRT1), because this protein downregulates stress-responsive inducers of cell death, such as the tumor suppressor p53, [14] [15] [16] apoptosis factor of the Bcl-2 family (BAX) 17 and the forkhead family of transcription factors. 18, 19 CR also induces many endocrine changes in mammals, and it has been suggested that at least some of these changes may be mediated by SIRT1. 6 For example, the reduction in white adipose tissue (WAT) appears to be a primary factor in the longevity induced by CR, since mice engineered to have less WAT live longer, even though they do not eat less. 20 The life-extending effect of CR is due to alterations in a number of physiological processes. 21 At least two of these processes are tightly related to the biology of WAT. Specifically, CR blunts sexual maturation and fertility, which allows longterm survival through energy sparing, 22 and reverses aginginduced reduction in insulin resistance. [23] [24] [25] [26] Reproductive function and insulin resistance are both closely related to body fat mass and are both affected by hormones produced by adipocytes. 27 Besides these, free fatty acids (FFA), released in the circulation as a result of lipolysis in WAT, also strongly induce insulin resistance when they are not promptly oxidized in other tissues. From these observations, it is possible that aging contributes to metabolic diseases through modulation of fat accumulation in WAT and/or adipose-derived hormone production/signaling via affecting the activity of crucial regulators of adipocyte functions.
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Age-associated metabolic diseases
In humans, age per se is a strong risk factor for fat accumulation. 31 The recent change in demographic curves in industrialized countries towards an elderly population has synergized with the rise in the intake of energy-rich diets to exacerbate the obesity epidemic. Moreover, people of a few countries known for their longevity have experienced lower longevity expectations following the change in nutritional conditions towards energy-rich food. It is generally accepted that, without the introduction of recent pharmacological tools, obesity and its co-morbidities would decrease the lifespan. It is well established that aging is associated with the progressive development of general insulin resistance 32,33 of insulin-mediated processes such as glucose uptake in peripheral tissues, 34, 35 inhibition of lipolysis, [36] [37] [38] [39] and hepatic control of glucose production 40 and triglyceride secretion. 41 This reduction in insulin sensitivity upon aging is closely related to the accumulation of fat, especially in the abdominal cavity. 21, [42] [43] [44] The mass of adipose tissue results from the balance between adipogenesis and adipocyte apoptosis on the one hand, and on the other hand between the rate of de novo fatty acid synthesis and of uptake of dietary FFA in adipocytes, and fatty acid release (lipolysis) and transport to oxidizing tissues. Aging is associated with decreased lipolytic capacity and increased synthesis and uptake in adipocytes, whereas fatty acid oxidation in skeletal muscle appears to be reduced. 31 Many of these complications are directly responsible for some illnesses and diseases in older people such as type 2 diabetes and atherosclerosis, which usually develop from the fourth decade of life. The molecular mechanisms for age-induced insulin resistance and fat accretion are, however, far from being completely understood.
Aging and fat: SIRT1 as a molecular link SIRT1 is ubiquitously expressed and is present in WAT. At least in rodents, it is also found in brown adipose tissue (BAT). We recently found 45 that overexpression of SIRT1 in a cell model of white adipocytes, the 3T3-L1 cells, reduces adipogenesis and triglyceride accumulation in the lipid droplets of the cells. This phenomenon was associated with a diminished expression of genes involved in fatty acid trapping, such as adipose-specific fatty acid-binding protein (aP2), CAAT enhancer-binding protein alpha (C/EBPa), and peroxisome proliferator-activated receptors gamma (PPARg).
In mature adipocytes, stimulation of SIRT1 activity by a small molecule found in red grapes, resveratrol, promotes lipolysis and a reduction in fat accretion. SIRT1 was found to bind to and repress PPARg activity by docking PPARg corepressors, nuclear receptor corepressor (NcoR) and silencing mediator for retinoid and thyroid hormone receptor (SMRT). The complex SIRT1/PPARg/NCoR is recruited to specific DNA sequences (PPARg response elements (PPRE)) in the promoter region of PPARg target genes, such as aP2, and inhibits their transcription (Figure 1 ). It is not yet known if the negative effect of SIRT1 on gene expression is due to deacetylation of the histones or a partner in the complex or both. In vivo, fasting induces the recruitment of SIRT1 to PPREs and promotes lipolysis by inhibiting PPARg-mediated fatty acid trapping. Lipolysis in isolated white adipocytes can also be potentiated by treatment with resveratrol, but only in the presence of catecholamines such as adrenaline, which suggests that signaling by the sympathetic nervous system contributes to the stimulation of SIRT1 activity. WAT, SIRT1 binds to PPARg and its corepressors NCoR and SMRT, and represses PPARg transcriptional activity. This effect would impact negatively on genes involved in fatty acid accumulation and would promote lipolysis. As a reduction of WAT can promote life extension, 20,46 SIRT1's effects on PPARg in WAT therefore possibly contribute to the antiaging affect of CR. In addition, the impact of SIRT1 on fat accretion will likely affect the production of adipose tissue-derived molecules and this could also modify the lifespan.
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Current work in the laboratory is investigating whether SIRT1-mediated supply of fatty acids from WAT is oxidized in other tissues such as muscle and BAT. Although still under verification, SIRT1 activity in BAT appears to be positive on energy expenditure and thermogenesis (Picard and Guarente, unpublished data). In addition, overexpression of SIRT1 in HIB fibroblasts promotes brown adipogenesis. Therefore, SIRT1, as a mediator of CR, can coordinate metabolism by favoring energy mobilization from WAT and oxidation in tissues like BAT.
Conclusions
The WAT now emerges as a very important and pivotal tissue controlling lifespan. Apart from the mentioned role of SIRT1 in WAT, a specific reduction in the fat body through overexpression of forkhead type transcription factor (dFOXO) in flies extends their life, 46 whereas, in mice, tissue-specific knockout of the insulin receptor also diminishes fat stores and extends lifespan. 20 Thus, there appears to be a general principle that a reduction in WAT increases lifespan across organisms. In addition to modifications in WAT-derived production of adipokines, it is likely that this diminution of WAT mass prevents the development of age-related metabolic diseases such as type 2 diabetes and atherosclerosis, since the progression of these disorders is in tight association with body fat mass.
